EPM looks at company relationships in the pharma sector to see which companies are teaming up for new developments and which companies are ‘taking a break’
Collaboration is difficult and involves conflict and debate, but the potential rewards for the pharmaceutical sector are worth the effort says Mike Straw, Achieve Breakthrough
The European Federation of Pharmaceutical Industries and Associations discusses the importance of its Partners in Research initiative to boost research in healthcare
Dr David Roblin, chief operating officer and director of scientific translation at the Francis Crick Institute in London, talks to EPM about the Institute’s recent partnership with GSK that will address a number of disease areas
Benjamin J Lehberger, St Onge Steward Johnston & Reens LLC, looks at patent challenges in the pharmaceutical industry and a recent trend of investment companies challenging the patents of foreign pharmaceutical manufacturers.
